Geller Biopharm is an investment bank founded in 2008 and based in New York, New York. The firm serves biotechnology and pharmaceutical clients with licensing, mergers and acquisitions, financial restructurings and advisory mandates. Geller Biopharma also advises on private and public financing transactions, including venture and crossover financings, PIPEs, registered directs, secondaries and initial public offerings.